The shares of this EPC inventory, offering turnkey options for prime and tremendous excessive rises, housing, city infrastructure and others got here into deal with Friday after receiving an order price Rs 1,320 crore from NBCC (India) Restricted.
Worth Motion
With a market capitalization of Rs 2,840.58 crore, Capacite Infraprojects Ltd fell 15 % on Friday’s buying and selling session to an intraday low of Rs 309.20 per share in comparison with its earlier closing worth of Rs 363 per share.
The inventory retraced from its day’s low and was buying and selling at Rs 336.15 which is 7.4 % decrease than the earlier closing worth.
What Occurred
Capacite Infraprojects Ltd was awarded a piece order of Rs 1,320 crore from NBCC (India) Restricted, a Navratna Enterprise, for the availability of EPC companies by Capacite for the event of Leisure Valley Part-II Residential Residences, at Larger Noida (U.P.). Moreover, the contract calls for provision of O&M companies for a interval of two years after the completion of the undertaking.
Additionally learn: Vrundavan Plantation in inexperienced after securing 2 work orders from Tata Group
Firm Overview
Capacite Infraprojects Ltd, specialising in EPC affords complete development companies for buildings and factories throughout numerous sectors. The corporate has to date delivered greater than 60 tasks throughout completely different constructing segments together with residential and business buildings for numerous functions like hospitality, healthcare and schooling.
Moreover, Capacite holds the Limca Ebook of Report for quickest hospital development. As of Q3 FY25, Capacite’s order e-book measurement stands at Rs 10,047 crore. About 63 % of this comes from public sector shoppers and the remaining 37 % from the non-public sector. The corporate’s marquee shoppers embrace famend names like CIDCO, BSNL, GIFT, Oberoi, Piramal, and DLF amongst others.
Ace Investor Holdings
Mukul Mahavir Agarwal, a outstanding ace investor in India holds a 6.09 % stake within the firm or 51.5 lakh fairness shares as of Q3 FY25.
Written by Shwetha Sairam
Disclaimer
The views and funding ideas expressed by funding consultants/broking homes/score businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of monetary losses. Traders should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the writer should not answerable for any losses induced because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
